Pseudocholinesterase levels and rates of chloroprocaine hydrolysis in patients receiving adequate doses of phospholine iodide.
D001049:Apnea / Q000139:chemically induced*; D002091:Butyrylcholinesterase / Q000378:metabolism*; D002802:Cholinesterases / Q000378:metabolism*; D004456:Echothiophate Iodide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011343:Procaine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D013390:Succinylcholine / Q000378:metabolism / Q000494:pharmacology
D011343:Procaine; C004616:chloroprocaine; D004456:Echothiophate Iodide; D002091:Butyrylcholinesterase; D002802:Cholinesterases; D013390:Succinylcholine